Isavuconazole as salvage therapy for mucormycosis
Mucormycosis carries a high mortality rate with few therapeutic options available. We describe a man with pulmonary/splenic mucormycosis complicating hypoplastic myelodysplastic syndrome on a background of chronic kidney disease, who achieved a complete response with salvage isavuconazole therapy fo...
Main Authors: | Bianca Graves, C. Orla Morrissey, Andrew Wei, John Coutsouvelis, Samantha Ellis, Alan Pham, Julian Gooi, Michelle Ananda-Rajah |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2016-03-01
|
Series: | Medical Mycology Case Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211753916300082 |
Similar Items
-
Isavuconazole in the treatment of invasive aspergillosis and mucormycosis infections
by: Donnelley MA, et al.
Published: (2016-06-01) -
Successful treatment of Rhizopus arrhizus rhino-orbital-cerebral mucormycosis with isavuconazole salvage therapy following extensive debridement
by: R.P. Miller, et al.
Published: (2021-06-01) -
Successful outcome of disseminated mucormycosis in a 3-year-old child suffering from acute leukaemia: the role of isavuconazole? A case report
by: Marjorie Cornu, et al.
Published: (2018-12-01) -
Role of isavuconazole in the treatment of invasive fungal infections
by: Wilson DT, et al.
Published: (2016-08-01) -
Isavuconazole for the treatment of invasive aspergillosis and mucormycosis: current evidence, safety, efficacy, and clinical recommendations
by: Natesan SK, et al.
Published: (2016-12-01)